Image de couverture de livre

Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Cheng Zhou, Xianchen Jiang, Xiaojun Guan, Tao Guo, Jingjing Wu, Haoting Wu, Chenqing Wu, Jingwen Chen, Jiaqi Wen, Sijia Tan, Xiaojie Duanmu, Jianmei Qin, Weijin Yuan, Qianshi Zheng, Peiyu Huang, Baorong Zhang, Xiaojun Xu, Minming Zhang
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	European Journal of Neurology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies
par: Jiaqi Wen, et autres
Publié: (2025)

Glymphatic Function in Prodromal Parkinson's Disease: Associations With Symptoms, Gray Matter Volume, and Phenoconversion Risk
par: Amei Chen, et autres
Publié: (2025)

Reconsidering Central and Peripheral Contributions to Propranolol's Anti Tremor Effects in Parkinson's Disease
par: Sijia Zhu, et autres
Publié: (2025)

Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis
par: Monica Margoni, et autres
Publié: (2024)

Sternocleidomastoid Muscle Overactivity: A Potentially Critical Contributor to Postural Abnormalities in Parkinson's Disease
par: Sha Zhu, et autres
Publié: (2025)

Understanding Parkinson disease in Spain: Genetic and clinical insights
par: Pilar Gómez‐Garre, et autres
Publié: (2024)

The rise and fall of Queckenstedt's test between 1916 and 1970, a milestone in spinal cord diagnostics and why it matters
par: Armin Curt, et autres
Publié: (2024)

Abnormal Amygdala Subregion Functional Connectivity in Patients with Crohn’s Disease with or without Anxiety and Depression
par: Jingwen Sun, et autres
Publié: (2024)

Glymphatic Dysfunction Reflects Post‐Concussion Symptoms: Changes Within 1 Month and After 3 Months
par: Eunkyung Kim, et autres
Publié: (2025)

Progression of hippocampal subfield atrophy and asymmetry in Alzheimer's disease
par: Jingjing Xu, et autres
Publié: (2024)

Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial
par: Joaquim J. Ferreira, et autres
Publié: (2025)

Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative
par: Daniel Weintraub, et autres
Publié: (2026)

From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI
par: Kenneth Marek, et autres
Publié: (2026)

The Relationship Between Cerebral Small Vessel Disease, Sleep Quality, and Cognitive Impairment Among Community‐Dwelling Older Adults: Exploring the Role of Glymphatic Function
par: Rong Zhou, et autres
Publié: (2025)

Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative
par: Paulina Gonzalez‐Latapi, et autres
Publié: (2026)

Combined Vascular Parkinsonism and Parkinson’s Disease: A Case Report
par: Mitsunori Morimatsu, et autres
Publié: (2026)

Pleiotropy and the Increasing Complexity of Parkinson's Disease Genetics
par: Jonggeol Kim, et autres
Publié: (2025)

Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker‐Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
par: Ethan G. Brown, et autres
Publié: (2026)

Circadian Syndrome Mediates the Association Between Body Roundness Index and Incident Stroke Risk in Middle‐Aged and Older Chinese Adults: A Nationwide Prospective Cohort Study
par: Gaiying Ma, et autres
Publié: (2026)

The Parkinson's Progression Markers Initiative: Why Then? Why Now?
par: Michael J. Fox
Publié: (2026)

Dysregulation of Gut Microbiota‐Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus‐Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic Analysis
par: Xue Chen, et autres
Publié: (2024)

Evaluation of Soluble Colony Stimulating Factor 1 Receptor (CSF1R) in Peripheral Blood as a Diagnostic Marker of CSF1R‐Related Disorder (CSF1R‐RD) in a Murine Model and CSF1R‐RD Patients
par: Banglian Hu, et autres
Publié: (2024)

Early BMI Change, Cognitive Decline, and CSF AD Biomarkers Alterations in Parkinson's Disease
par: Rui Zhong, et autres
Publié: (2025)

Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative
par: Lana M. Chahine, et autres
Publié: (2026)

Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
par: Verena Dzialas, et autres
Publié: (2025)

Heart Rate Profiles During Exercise and Incident Parkinson's Disease
par: Stefan van Duijvenboden, et autres
Publié: (2025)

Return of Individual Research Information in the Parkinson's Progression Markers Initiative
par: Thomas F. Tropea, et autres
Publié: (2026)

Autonomic Dysfunction and Risk of Mortality in Early‐Onset Parkinson's Disease
par: Capucine Piat, et autres
Publié: (2025)

Pelvic autonomic dysfunction is common in patients with pure autonomic failure
par: E. Vichayanrat, et autres
Publié: (2024)

Ocular motor and vestibular dysfunction in central nervous system lymphoma
par: Suk‐Min Lee, et autres
Publié: (2024)

Association between iron content in grey matter nuclei and functional outcome in patients with acute ischaemic stroke: A quantitative susceptibility mapping study
par: Yaqi Chen, et autres
Publié: (2024)

Re: Association Between Stress Hyperglycemia Ratio and Parkinson's Disease Across Different Glucose Metabolism Statuses—A Prospective Study From UK Biobank
par: Wenwen Xu, et autres
Publié: (2025)

The Clinical Effect of Annonaceae Fruit Consumption on Caribbean Parkinson′s Disease Severity
par: Louis Ribeyron, et autres
Publié: (2026)

Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's Disease
par: Deepika Dinesh, et autres
Publié: (2026)

Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease
par: Shannon Y. Chiu, et autres
Publié: (2026)

Reply to “An Apple a Day Will Not Keep the (Parkinson's Disease) Doctor at Bay!”
par: Erik Post, et autres
Publié: (2024)

Alterations of Cortical Structure and Neurophysiology in Parkinson's Disease Are Aligned with Neurochemical Systems
par: Alex I. Wiesman, et autres
Publié: (2024)

Remote levodopa challenge test in Parkinson's disease: Feasibility, reliability, validity and economic value
par: Zhitong Zeng, et autres
Publié: (2024)

Sleep disturbances, cognitive decline, and AD biomarkers alterations in early Parkinson's disease
par: Rui Zhong, et autres
Publié: (2024)

Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease
par: Yue Jing Heng, et autres
Publié: (2026)